Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
138 hedge funds and large institutions have $1.2B invested in Abiomed Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 17 closing their positions.
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
7% more capital invested
Capital invested by funds: $1.12B → $1.2B (+$76.4M)
1% more funds holding
Funds holding: 137 → 138 (+1)
9% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 47
19% less call options, than puts
Call options by funds: $254K | Put options by funds: $312K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tiger Global Management
New York
|
+$39.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.5M |
| 3 |
DCM
Decade Capital Management
New York
|
+$10.7M |
| 4 |
Millennium Management
New York
|
+$6.93M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$43.7M |
| 2 |
AIM
Assured Investment Management
New York
|
-$41.9M |
| 3 |
D.E. Shaw & Co
New York
|
-$5.26M |
| 4 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
-$4.58M |
| 5 |
VAM
Visium Asset Management
New York
|
-$3.05M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
Tudor Investment Corp
Stamford,
Connecticut
| – | -$292K | -11,200 | Closed |
|
|
WA
152
Whitebox Advisors
Minneapolis,
Minnesota
| – | -$281K | -10,800 | Closed |
|
|
NCCM
153
Nine Chapters Capital Management
Short Hills,
New Jersey
| – | -$216K | -8,300 | Closed |
|
|
1GA
154
1st Global Advisors
Dallas,
Texas
| – | -$213K | -8,162 | Closed |
|
|
PA
155
Perceptive Advisors
New York
| – | -$130K | -5,000 | Closed |
|
ABMD Hedge Fund Activity: Q2 2014 in Review
138 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2014, worth a combined $1.2B — up 6.8% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ABMD positions and 17 closed out — a net gain of 2 holders — while 43 added to existing stakes and 47 trimmed.
The largest buyer was Tiger Global Management, opening a new position worth an estimated $39.3M. The largest seller was Macquarie Group, cutting an estimated $43.7M.
- 138 institutional investors held Abiomed Inc (ABMD) as of Q2 2014, up from 137 in Q1 2014.
- Funds reported $1.2B of Abiomed Inc stock for Q2 2014, up 6.8% quarter-over-quarter.
- 19 funds opened new Abiomed Inc positions in Q2 2014 and 17 closed out, a net change of +2 holders.
- The largest Abiomed Inc buyer in Q2 2014 was Tiger Global Management, an estimated $39.3M added.
- The largest Abiomed Inc seller in Q2 2014 was Macquarie Group, an estimated $43.7M sold.
Based on aggregated 13F filings for Q2 2014.